Clinical trial
PROGNOSTIC EVALUATION OF SEVERE SEPSIS AND SEPTIC SHOCK. PROCALCITONIN VERSUS DELTA SOFA
NCT01841190 is registered in ClinicalTrials.gov with Hospital Sao Domingos as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PROGNOSTIC EVALUATION OF SEVERE SEPSIS AND SEPTIC SHOCK. PROCALCITONIN VERSUS DELTA SOFA
- Lead sponsor
- Hospital Sao Domingos
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 31, 2012
- Completion date
- Not reported
- Enrollment
- 128 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
septic shock, severe sepsis